2 个月
GlobalData on MSNFDA protocol deviation guidance could go furtherVera Pomerantseva (VP): Protocol deviation management is not a new process in the industry - it's rather complex. There is a ...
Serious breach: Any deviation of the approved protocol version or the clinical trial regulation that is likely to affect the safety, rights of trial participants and/or data reliability and robustness ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果